TYRA Biosciences (NASDAQ: TYRA) net income
TYRA Biosciences reported a net loss of $119.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $86.5m. Earnings per share were −$2.01.
TYRA Biosciences's best year of the last 6 was fiscal 2020. It reported a loss in 6 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$119.9m | — | — | −$2.01 |
| 2024 | −$86.5m | — | — | −$1.51 |
| 2023 | −$69.1m | — | — | −$1.62 |
| 2022 | −$55.3m | — | — | −$1.32 |
| 2021 | −$26.3m | — | — | −$1.91 |
| 2020 | −$9.3m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
TYRA Biosciences net income compared with its sector
By net income for its latest fiscal year, TYRA Biosciences ranks 355th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 353rd | Savara | −$118.8m | — |
| 354th | Voyager Therapeutics | −$119.7m | −296.5% |
| 355th | TYRA Biosciences | −$119.9m | — |
| 356th | Acumen Pharmaceuticals | −$121.3m | — |
| 357th | Tilray Brands | −$121.4m | −13.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of TYRA Biosciences
- How much did TYRA Biosciences earn in fiscal 2025?
- TYRA Biosciences reported a net loss of $119.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $86.5m.
- What are the earnings per share of TYRA Biosciences?
- They were −$2.01 in fiscal 2025, compared with −$1.51 in fiscal 2024.
- Where does TYRA Biosciences rank in its sector by net income?
- It ranks 355th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for TYRA Biosciences come from?
- From the annual report (Form 10-K) that TYRA Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that TYRA Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on TYRA Biosciences: the TYRA Biosciences page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.